查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2001068

眼科黏合劑和密封劑市場：2026-2032年全球市場預測（按產品類型、配方、給藥途徑、分銷管道、應用和最終用戶分類）

Ocular Adhesives & Sealants Market by Product Type, Formulation, Route of Administration, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，眼科黏合劑和密封劑市場價值將達到 3.7429 億美元，到 2026 年將成長至 4.1627 億美元，到 2032 年將達到 7.1173 億美元，年複合成長率為 9.61%。

主要市場統計數據
基準年 2025 3.7429億美元
預計年份：2026年 4.1627億美元
預測年份 2032 7.1173億美元
複合年成長率 (%) 9.61%

臨床、技術、監管和商業性趨勢策略概述，塑造眼科黏合劑和密封劑的未來

眼科黏合劑和密封劑市場處於外科創新、生物材料科學和不斷發展的臨床實踐的交匯點。近年來，臨床醫生一直在尋求替代縫合技術的方案，以提高患者舒適度、縮短手術時間並確保穩定的臨床療效。同時，生物材料化學和器械輸送技術的進步拓寬了眼科醫師和從業人員可選擇的治療方案。因此，這種融合催生了除傳統傷口縫合之外的新應用，例如止血以及晶狀體固定和組織粘連等特殊手術。

生物材料、微創手術、監管要求和數位技術的進步如何推動眼科黏合劑和密封劑的綜合發展。

眼科黏合劑和密封劑領域正在發生多項變革性變化，重塑著研究、臨床實踐和商業化的優先順序。首先，材料科學的突破催生了結合合成聚合物和生物活性成分的混合解決方案，拓展了黏合劑的功能範圍，使其不再局限於機械性組織介入，而是能夠主動止血和促進組織整合。其次，微創手術技術的進步和門診手術數量的增加，推動了對能夠支持快速應用和穩定治療效果的製劑和給藥系統的需求。

本研究評估了近期貿易政策調整和關稅趨勢對眼科生物材料的籌資策略、製造地和商業計劃的影響。

政策環境和國際貿易措施會對眼科黏合劑和密封劑中使用的醫療設備和生物組件的供應鏈、原料採購和定價策略產生重大影響。近期主要經濟體的關稅決策和貿易政策變化，要求供應鏈進一步多元化，迫使製造商重新評估其組件採購、製造地和庫存策略。為此，許多企業正在加速關鍵生產流程的在地化，並選擇替代供應商以降低供應中斷的風險。

詳細的細分分析揭示了產品類型、配方、給藥途徑、應用、最終用戶和分銷管道如何全面決定臨床引入和商業策略。

了解基於細分市場的趨勢，有助於在整個眼科黏合劑和密封劑領域做出更精準的產品和市場准入決策。在考慮產品類型差異時，黏合劑和密封劑在市場上有所區別，它們各自服務於不同的機械和臨床應用，並影響應用技術和器械設計。在配方層面，生物製劑和合成製劑之間存在著明確的界線。生物製藥通常含有白蛋白或纖維蛋白成分，優先考慮生物相容性和組織整合性；而合成製劑則利用氰基丙烯酸酯、聚乙二醇（PEG）聚合物和聚氨酯等化學物質，以實現可調的機械性能和多樣化的分解特性。

從跨區域觀點分析美洲、歐洲、中東和非洲以及亞太市場在監管差異、臨床引入模式和供應鏈策略方面的細微差別。

區域趨勢影響眼科黏合劑和密封劑的監管路徑、臨床醫生的偏好以及供應鏈發展。在美洲，先進的外科中心集中分佈，且管理體制強調臨床證據，這使得創新配方和給藥系統能夠被有影響力的關鍵意見領袖（KOL）快速評估和採納。因此，人們更重視完善的臨床通訊協定和上市後資料收集，以支援這些產品在不同醫療機構的應用。

競爭動態、聯盟和生命週期管理策略正在決定哪些公司將制定眼科黏合劑和密封劑的臨床標準，並影響這些標準的採用。

眼科黏合劑和密封劑產業的競爭與合作動態正在演變，各公司正優先考慮平台差異化、合規性和有針對性的臨床夥伴關係。業內公司正投資研發獨特的化學和遞送技術，以滿足尚未滿足的臨床需求，例如提高黏合強度和減少複雜眼組織中的發炎反應。許多公司也在尋求與臨床研究中心建立策略合作夥伴關係，以加速證據產生並建立一個能夠檢驗臨床效用的外科醫生網路。

為了加快眼科黏合劑和密封劑的採用，需要採取切實可行的優先措施，協調研發、監管合規計畫、供應鏈彈性和商業策略，以指導高層管理。

產業領導者應採取協調一致的策略，使研發重點與監管、臨床和商業要求保持一致。他們應投資於兼顧黏附性和生物相容性的製劑科學，並設計能夠無縫整合到典型眼科工作流程中的給藥系統，以減少臨床實踐中的阻力。在產品開發的同時，他們還應實施有針對性的臨床證據產生計劃，將隨機臨床評估與可操作的真實世界研究相結合，以建立監管文件和實施方案。

為了確保獲得可靠且實用的見解，我們採用了嚴格的混合方法，結合了對臨床醫生的初步訪談、對二手文獻的檢驗以及專家檢驗。

本研究整合了第一手和第二手調查方法，以確保分析的嚴謹性和實際應用價值。第一手資料收集包括對臨床外科醫師、採購經理和醫療設備研發經理進行結構化訪談，從而深入了解手術流程、臨床醫師偏好和採購行為。第二手研究則包括對同儕審查期刊、監管指南、醫療設備註冊庫和公開臨床試驗註冊庫進行系統性回顧，以驗證臨床表現特徵與監管先例的檢驗。

結論分析強調，與臨床醫生需求相符的創新、實證應用和運作韌性是眼科黏合劑和密封劑成功的關鍵決定因素。

眼科黏合劑和密封劑正透過材料創新、手術效率和臨床需求的融合，重塑眼科手術實踐。無論配方或給藥方法如何，最成功的干涉措施都將展現出明顯的臨床益處，無縫融入外科醫生的工作流程，並滿足監管和採購要求。配方選擇——無論是生物來源的選項（如白蛋白和纖維蛋白），還是合成化學物質（如氰基丙烯酸酯、聚乙二醇聚合物和聚氨酯）——將繼續決定產品的差異化和臨床效用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：眼科黏合劑和密封劑市場：按產品類型分類

  • 黏合劑
  • 密封劑

第9章：眼科黏合劑和密封劑市場（按配方分類）

  • 生物來源
    • 白蛋白
    • 纖維蛋白
  • 合成
    • 氰基丙烯酸酯
    • PEG系統
    • 聚氨酯

第10章：眼科黏合劑和密封劑市場：依給藥途徑分類

  • 注射藥物
  • 外用

第11章：眼科黏合劑和密封劑市場：按分銷管道分類

  • 直銷
  • 銷售代理
  • 網路藥房

第12章：眼科黏合劑和密封劑市場：按應用領域分類

  • 止血
  • 鏡頭固定
  • 組織沾黏
  • 傷口縫合

第13章：眼科黏合劑和密封劑市場：按最終用戶分類

  • 門診手術中心
  • 醫院
  • 眼科診所

第14章：眼科黏合劑和密封劑市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：眼科黏合劑和密封劑市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 眼科黏合劑和密封劑市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國眼科黏合劑與密封劑市場

第18章：中國眼科黏合劑與密封劑市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton Dickinson & Company
  • Concord Drugs Ltd.
  • Connexicon Medical Limited
  • Corza Medical
  • Cryolife Inc.
  • CSL Behring LLC
  • Grena Ltd.
  • HB Fuller Company
  • Johnson & Johnson Services, Inc.
  • Ocular Therapeutix, Inc.
  • Reliance Life Sciences
  • Stryker Corporation
  • Surgitech Innovation
  • Vivostat A/S
Product Code: MRR-F927BA461E88

The Ocular Adhesives & Sealants Market was valued at USD 374.29 million in 2025 and is projected to grow to USD 416.27 million in 2026, with a CAGR of 9.61%, reaching USD 711.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 374.29 million
Estimated Year [2026] USD 416.27 million
Forecast Year [2032] USD 711.73 million
CAGR (%) 9.61%

A strategic overview of the clinical, technological, regulatory, and commercial dynamics shaping the future of ocular adhesives and sealants

The ocular adhesives and sealants landscape sits at the intersection of surgical innovation, biomaterials science, and evolving clinical practice. In recent years clinicians have sought alternatives to suture-based techniques that offer improved patient comfort, reduced procedure time, and consistent clinical outcomes. At the same time, advances in biomaterial chemistry and device delivery technologies have expanded the palette of therapeutic options available to ophthalmic surgeons and proceduralists. Consequently, this convergence has unlocked new applications beyond traditional wound closure, including hemostasis and specialized tasks like lens fixation and tissue adhesion.

Transitioning from concept to clinical adoption requires synchronized progress across regulatory clarity, clinician training, and supply chain reliability. Developers are increasingly prioritizing formulations that balance adhesive strength with biocompatibility and ease of application. In parallel, the distribution and commercialization models are maturing, with direct sales channels and distributor partnerships playing crucial roles in enabling adoption across ambulatory surgical centers, hospitals, and ophthalmic clinics. These dynamics set the stage for practitioners and industry stakeholders to make informed choices about investment, clinical trials, and post-market surveillance strategies.

How concurrent advances in biomaterials, minimally invasive surgery, regulatory expectations, and digital enablement are driving an integrated evolution in ophthalmic adhesives and sealants

Several transformative shifts are reordering priorities across research, clinical practice, and commercialization in the ocular adhesives and sealants field. First, material science breakthroughs are producing hybrid solutions that combine synthetic polymers with bioactive components, which in turn are expanding the functional scope of adhesives beyond mechanical approximation to include active hemostasis and tissue integration. Second, minimally invasive surgical techniques and growing volumes of ambulatory procedures have increased demand for formulations and delivery systems that support rapid application and consistent outcomes.

Concurrently, regulatory pathways and payer scrutiny are steering developers toward clearer evidence-generation strategies. Manufacturers are responding by designing clinical programs that emphasize real-world performance metrics, patient-reported outcomes, and device-user ergonomics. Digital health enablers, such as procedure documentation and remote training platforms, are accelerating clinician uptake and scaling educational efforts. Taken together, these shifts create a more integrated ecosystem where innovations in chemistry, delivery, clinical validation, and commercialization reinforce one another and accelerate the translation of novel adhesives and sealants into routine ophthalmic practice.

Evaluating how recent trade policy adjustments and tariff developments are reshaping sourcing strategies, manufacturing footprints, and commercial planning for ocular biomaterials

The policy environment and international trade measures can exert material influence on supply chains, ingredient sourcing, and pricing strategies for medical device and biologic components used in ocular adhesives and sealants. Recent tariff decisions and trade policy shifts in major economies have necessitated greater supply chain diversification and have prompted manufacturers to reassess component sourcing, manufacturing footprint, and inventory strategies. In response, many organizations are accelerating localization of critical manufacturing steps and qualifying alternative suppliers to mitigate the risk of supply disruption.

Moreover, procurement teams and commercial leads are increasingly incorporating tariff exposure into contract negotiations and total cost of ownership analyses. This implies more rigorous scenario planning for clinical trials, regulatory submissions, and product launches across different regions. From a strategic perspective, firms that proactively adjust sourcing strategies, enhance supplier redundancy, and optimize logistics will be better positioned to maintain clinical supply continuity and protect margins under fluctuating trade conditions.

Deep segmentation analysis revealing how product types, formulations, routes, applications, end users, and distribution channels collectively determine clinical adoption and commercial strategy

Understanding segmentation-driven dynamics enables sharper product and go-to-market decisions across the ocular adhesives and sealants space. When considering product type differentiation, the market distinguishes between adhesives and sealants, each serving distinct mechanical and clinical purposes with implications for application technique and device design. Formulation-level segmentation draws a clear line between biological and synthetic approaches; biological formulations commonly incorporate albumin or fibrin components and emphasize biocompatibility and tissue integration, whereas synthetic formulations leverage chemistries such as cyanoacrylate, PEG-based polymers, and polyurethane to deliver tunable mechanical properties and variable degradation profiles.

Route of administration matters for both clinical workflow and regulatory classification, as developers target injectable solutions for posterior or intraocular applications and topical formats for anterior procedures and wound access. Application-focused segmentation highlights use cases including hemostasis, lens fixation, tissue adhesion, and wound closure, each of which imposes unique performance and safety requirements. End-user segmentation underscores differing adoption pathways and purchasing behaviors among ambulatory surgical centers, hospitals, and ophthalmic clinics, influencing training, reimbursement interactions, and inventory strategies. Finally, distribution channels-ranging from direct sales to partnerships with distributors and transactions via online pharmacies-shape service models, product support expectations, and post-market surveillance mechanisms. Integrating these segmentation lenses informs product design, clinical evidence generation, and tailored commercial approaches that align with clinician workflows and institutional procurement practices.

Cross-regional perspectives on regulatory nuance, clinical adoption patterns, and supply chain strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics influence regulatory pathways, clinician preferences, and supply chain architectures for ocular adhesives and sealants. In the Americas, a strong concentration of advanced surgical centers and a regulatory regime that emphasizes clinical evidence create an environment where novel formulations and delivery systems can be rapidly evaluated and adopted by influential key opinion leaders. This drives an emphasis on robust clinical protocols and post-market data capture to support adoption across diverse care settings.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and regional procurement dynamics vary significantly, prompting manufacturers to tailor registration strategies and commercial models to local requirements. In some jurisdictions, cost containment pressures and hospital purchasing group dynamics necessitate a focus on value demonstration and ease of training. The Asia-Pacific region exhibits a mix of rapidly modernizing healthcare infrastructures and high-volume surgical throughput centers, which creates demand for scalable, cost-effective solutions and localized manufacturing partnerships. Collectively, these regional variations require flexible regulatory planning, adaptable training programs, and distribution strategies that respect local clinical practice patterns and procurement processes.

How competitive dynamics, collaborations, and lifecycle management strategies are determining which companies set clinical standards and influence adoption for ocular adhesives and sealants

Competitive and collaborative dynamics among companies active in ocular adhesives and sealants have evolved to prioritize platform differentiation, regulatory navigation, and targeted clinical partnerships. Industry players are investing in proprietary chemistries and delivery technologies to address unmet clinical needs such as improving adhesive strength in challenging ocular tissues and reducing inflammatory responses. Many organizations are also seeking strategic collaborations with clinical research centers to expedite evidence generation and establish surgeon champions who can validate real-world utility.

At the same time, consolidation and licensing arrangements are common as manufacturers balance the capital intensity of late-stage clinical trials with the need to scale commercial operations. Companies that combine deep regulatory expertise with agile development processes and strong clinician engagement models tend to secure favorable adoption trajectories. Furthermore, firms that prioritize lifecycle management-iterative product improvements driven by post-market feedback-can strengthen competitive positioning and create enduring clinical preference.

Practical, prioritized actions for executives to align R&D, regulatory planning, supply chain resilience, and commercial tactics to accelerate adoption of ocular adhesive and sealant technologies

Industry leaders should adopt a coordinated strategy that aligns R&D priorities with regulatory, clinical, and commercial imperatives. Invest in formulation science that balances adhesive performance with biocompatibility, and design delivery systems that integrate effortlessly into common ophthalmic workflows to reduce friction at the point of care. Parallel to product development, implement targeted clinical evidence generation plans that pair randomized clinical evaluation with pragmatic real-world studies to build both regulatory dossiers and adoption narratives.

Operationally, diversify supplier bases and consider regional manufacturing or packaging capabilities to hedge against trade-related disruptions. From a commercialization perspective, tailor engagement strategies to end users: develop focused education and training packages for ambulatory surgical centers, extensive clinical support and service agreements for hospitals, and practical implementation guides for ophthalmic clinics. Finally, pursue partnerships that accelerate access to high-volume procedure centers and leverage digital training tools to scale surgeon familiarity and competency with new adhesive and sealant technologies.

A rigorous mixed-methods approach combining primary clinician interviews, secondary literature triangulation, and expert validation to ensure reliable and actionable insights

This research synthesizes primary and secondary methodologies to ensure analytical rigor and practical relevance. Primary data collection included structured interviews with clinical surgeons, procurement directors, and device development leaders, which provided contextual insights into procedural workflows, clinician preferences, and purchasing behavior. Secondary research incorporated a systematic review of peer-reviewed journals, regulatory guidances, device registries, and publicly available clinical trial registries to triangulate clinical performance attributes and regulatory precedents.

Analytical methods combined qualitative thematic analysis of stakeholder interviews with cross-validation against secondary sources. Validation exercises included expert panel reviews and iterative reconciliations where discrepancies were identified. Limitations of the methodology are acknowledged: while efforts were made to secure diverse perspectives across geographies and care settings, rapidly evolving clinical practices and local reimbursement nuances may produce variability that requires ongoing surveillance. Consequently, the findings should be used as a directional guide to inform strategy, while recognizing the need for continuous market monitoring and targeted primary research for specific product or geographic questions.

Concluding analysis emphasizing clinician-aligned innovation, evidence-led adoption, and operational resilience as the critical determinants of success in ocular adhesives and sealants

Ocular adhesives and sealants represent a convergence of material innovation, procedural efficiency, and clinical need that is reshaping ocular surgery practice. Across formulations and delivery modalities, the most successful interventions will be those that demonstrate clear clinical benefits, integrate with surgeon workflows, and align with regulatory and procurement expectations. The interplay of formulation choices-whether biological options like albumin and fibrin or synthetic chemistries such as cyanoacrylate, PEG-based polymers, and polyurethane-will continue to define product differentiation and clinical utility.

Stakeholders who align development priorities with end-user requirements, pursue robust evidence generation, and build resilient supply chains will be better positioned to translate technological promise into sustained clinical adoption. Ultimately, pragmatic strategies that balance innovation with operational excellence and clinician-centric commercialization will determine which solutions achieve meaningful traction in diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ocular Adhesives & Sealants Market, by Product Type

  • 8.1. Adhesives
  • 8.2. Sealants

9. Ocular Adhesives & Sealants Market, by Formulation

  • 9.1. Biological
    • 9.1.1. Albumin
    • 9.1.2. Fibrin
  • 9.2. Synthetic
    • 9.2.1. Cyanoacrylate
    • 9.2.2. PEG-Based
    • 9.2.3. Polyurethane

10. Ocular Adhesives & Sealants Market, by Route of Administration

  • 10.1. Injectable
  • 10.2. Topical

11. Ocular Adhesives & Sealants Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online Pharmacies

12. Ocular Adhesives & Sealants Market, by Application

  • 12.1. Hemostasis
  • 12.2. Lens Fixation
  • 12.3. Tissue Adhesion
  • 12.4. Wound Closure

13. Ocular Adhesives & Sealants Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Ophthalmic Clinics

14. Ocular Adhesives & Sealants Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Ocular Adhesives & Sealants Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Ocular Adhesives & Sealants Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Ocular Adhesives & Sealants Market

18. China Ocular Adhesives & Sealants Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International, Inc.
  • 19.8. Becton Dickinson & Company
  • 19.9. Concord Drugs Ltd.
  • 19.10. Connexicon Medical Limited
  • 19.11. Corza Medical
  • 19.12. Cryolife Inc.
  • 19.13. CSL Behring LLC
  • 19.14. Grena Ltd.
  • 19.15. H.B. Fuller Company
  • 19.16. Johnson & Johnson Services, Inc.
  • 19.17. Ocular Therapeutix, Inc.
  • 19.18. Reliance Life Sciences
  • 19.19. Stryker Corporation
  • 19.20. Surgitech Innovation
  • 19.21. Vivostat A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FIBRIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PEG-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY LENS FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY TISSUE ADHESION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 160. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. GCC OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 187. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 188. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 189. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. G7 OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 196. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 197. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. NATO OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA OCULAR ADHESIVES & SEALANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)